<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00531635</url>
  </required_header>
  <id_info>
    <org_study_id>RAC#2001-051</org_study_id>
    <nct_id>NCT00531635</nct_id>
  </id_info>
  <brief_title>Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA &amp; Mycophenolate Mofetil</brief_title>
  <official_title>Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA &amp; Mycophenolate Mofetil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Faisal Specialist Hospital &amp; Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Faisal Specialist Hospital &amp; Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC
      Infusion and post transplant in immunosuppression w/CSA &amp; Mycophenolate Mofetil
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2002</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>2001-2012</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Post Transplant in Immunosuppression w/CSA &amp; Mycophenolate Mofetil</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mycophenolate Mofetil</intervention_name>
    <description>Induction of Mixed Hemopoietic Chimerism in Patients Using Mycophenolate Mofetil</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients receiving Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in
             immunosuppression w/CSA &amp; Mycophenolate Mofetil.

        Exclusion Criteria:

          -  Uncontrolled major medical illnesses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Aljurf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KFSH&amp;RC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud AlJurf, MD</last_name>
    <phone>966-1-4647272</phone>
    <phone_ext>24586</phone_ext>
    <email>maljurf@kfshrc.edu.sa</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ed Colcol</last_name>
    <phone_ext>38005</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KFSH&amp;RC</name>
      <address>
        <city>Riyadh</city>
        <zip>11211</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud Aljurf, MD</last_name>
      <phone>966-1-4647272</phone>
      <phone_ext>24586</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Ed Colcol</last_name>
      <phone>966-1-4647272</phone>
      <phone_ext>38015</phone_ext>
      <email>colcol@kfshrc.edu.sa</email>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud Aljurf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2007</study_first_submitted>
  <study_first_submitted_qc>September 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2007</study_first_posted>
  <last_update_submitted>December 11, 2011</last_update_submitted>
  <last_update_submitted_qc>December 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fludarabine</mesh_term>
    <mesh_term>Fludarabine phosphate</mesh_term>
    <mesh_term>Mycophenolic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

